Race Oncology Limited

ASX:RAC.AX

1.585 (AUD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q22015 Q1
Revenue 04.0031.8121.32200.70800.38700.15900.22900.1700000000
Cost of Revenue 0.7690.1410.1410.1410.1410.1410.1410.1410.1410.1410.1410.3730.0480.54500000000
Gross Profit -0.7693.8631.6721.181-0.1410.567-0.1410.247-0.1410.019-0.141-0.144-0.048-0.37500000000
Gross Profit Ratio 00.9650.9220.89400.80100.63700.1180-0.6310-2.20200000000
Reseach & Development Expenses 4.8726.1054.4283.1673.5462.2861.6640.5360.7360.5410.5090.6560.6270.6570.7140.497000000
General & Administrative Expenses 0.4610.4530.9490.5760.3020.3130.3430.3270.2750.2120.2010.2170.2560.2620.2610.1930.2380.130.07400.0050.002
Selling & Marketing Expenses 0.1260.3060.2110.1120.0890.0870.1010.0730.0670.0370.0620.1820.7140.4970.2470.3040.05400000
SG&A 2.3223.3682.8492.2622.5252.8482.3021.6941.50.9020.9331.0071.982.2151.1191.4610.2930.130.07400.0050.002
Other Expenses 0000000000000000000000
Operating Expenses 7.1959.4737.2775.4296.075.1343.9662.2292.2361.4431.4431.8942.7823.1232.12.0970.1280.2060.08100.0060.003
Operating Income -7.964-9.613-7.418-5.569-6.211-5.275-4.106-2.37-2.377-1.583-1.583-2.035-2.827-3.495-2.087-2.097-0.262-0.168-0.0840-0.006-0.003
Operating Income Ratio 0-2.401-4.093-4.2130-7.4520-6.1170-9.9350-8.9070-20.52700000000
Total Other Income Expenses Net -0.192-0.0530.094-0.164-0.169-0.255-0.174-0.0780.033-0.078-0.0490.0080.0090.007-0.0030.0160.145-0.0320.003000
Income Before Tax -8.156-9.667-7.324-5.734-6.38-5.53-4.28-2.447-2.344-1.661-1.632-2.027-2.818-3.488-2.09-2.081-0.118-0.2-0.0810-0.006-0.003
Income Before Tax Ratio 0-2.415-4.041-4.3370-7.8120-6.3180-10.4250-8.8710-20.48900000000
Income Tax Expense 0-4.003-1.812-1.3220-0.7080-0.3870-0.1590000000.145-0.0320.003000
Net Income -8.156-5.663-5.512-4.412-6.38-4.822-4.28-2.06-2.344-1.502-1.632-2.027-2.818-3.488-2.09-2.081-0.118-0.2-0.0810-0.006-0.003
Net Income Ratio 0-1.415-3.041-3.3370-6.8120-5.3180-9.4250-8.8710-20.48900000000
EPS -0.049-0.035-0.034-0.027-0.04-0.033-0.032-0.016-0.021-0.015-0.02-0.026-0.04-0.055-0.04-0.04-0.01-0.018-0.0030-00
EPS Diluted -0.049-0.035-0.034-0.027-0.04-0.033-0.032-0.016-0.021-0.015-0.02-0.026-0.04-0.055-0.04-0.04-0.01-0.018-0.0030-00
EBITDA -8.272-9.473-7.277-5.429-6.07-5.134-3.966-2.229-2.236-1.443-1.443-1.895-2.701-3.37-1.92-2.0140.145-0.0320.003000
EBITDA Ratio 0-2.366-4.015-4.1060-7.2540-5.7550-9.0530-8.2920-19.79300000000